Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni

Showing results (51-60 of 325) with videos related to

Pageof 33
Sort By:
Nature Immunology|July 5, 2005
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cellsGiorgio Napolitani, Andrea Rinaldi, Francesco Bertoni, et al.
Leukemia & Lymphoma|November 4, 2014
The transcription factor ETS1 in lymphomas: friend or foe?Monica Testoni, Elaine Yee Lin Chung, Valdemar Priebe, et al.
Cancer Science|May 10, 2012
Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cellsMichela Boi, Anastasios Stathis, Emanuele Zucca, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Genome-wide DNA profiling of HIV-related B-cell lymphomasAndrea Rinaldi, Daniela Capello, Emanuele Zucca, et al.
European Journal of Internal Medicine|April 16, 2013
The changing paradigm of chronic lymphocytic leukemia managementChiara Lobetti-Bodoni, Francesco Bertoni, Georg Stussi, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
Clinical Lymphoma|November 19, 2002
Mantle cell lymphoma: new treatments targeted to the biologyFrancesco Bertoni, Michele Ghielmini, Franco Cavalli, et al.
British Journal of Haematology|December 21, 2018
In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomasChiara Tarantelli, Eugenio Gaudio, Luciano Cascione, et al.
Hematological Oncology|September 17, 2019
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphomaPatrizia Mondello, Salvatore Cuzzocrea, Carmela Arrigo, et al.
Hematological Oncology|January 23, 2014
MYC network mutations in high-risk chronic lymphocytic leukaemiaSara Monti, Clara Deambrogi, Andrea Rinaldi, et al.
Pageof 33

Showing results (51-60 of 325) with videos related to

Sort By:
Pageof 33
Nature Immunology|July 5, 2005
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cellsGiorgio Napolitani, Andrea Rinaldi, Francesco Bertoni, et al.
Leukemia & Lymphoma|November 4, 2014
The transcription factor ETS1 in lymphomas: friend or foe?Monica Testoni, Elaine Yee Lin Chung, Valdemar Priebe, et al.
Cancer Science|May 10, 2012
Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cellsMichela Boi, Anastasios Stathis, Emanuele Zucca, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Genome-wide DNA profiling of HIV-related B-cell lymphomasAndrea Rinaldi, Daniela Capello, Emanuele Zucca, et al.
European Journal of Internal Medicine|April 16, 2013
The changing paradigm of chronic lymphocytic leukemia managementChiara Lobetti-Bodoni, Francesco Bertoni, Georg Stussi, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
Clinical Lymphoma|November 19, 2002
Mantle cell lymphoma: new treatments targeted to the biologyFrancesco Bertoni, Michele Ghielmini, Franco Cavalli, et al.
British Journal of Haematology|December 21, 2018
In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomasChiara Tarantelli, Eugenio Gaudio, Luciano Cascione, et al.
Hematological Oncology|September 17, 2019
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphomaPatrizia Mondello, Salvatore Cuzzocrea, Carmela Arrigo, et al.
Hematological Oncology|January 23, 2014
MYC network mutations in high-risk chronic lymphocytic leukaemiaSara Monti, Clara Deambrogi, Andrea Rinaldi, et al.
Pageof 33